国际中医中药杂志
國際中醫中藥雜誌
국제중의중약잡지
INTERNATIONAL JOURNAL OF TRIDITIONAL CHINESE MEDICINE
2014年
10期
883-885
,共3页
邵魁卿%李奇%曾凡雄%李丁%高瞻%沈建武
邵魁卿%李奇%曾凡雄%李丁%高瞻%瀋建武
소괴경%리기%증범웅%리정%고첨%침건무
苓芍枣仁颗粒%酒石酸托特罗定片%膀胱过度活动症%尿急
苓芍棘仁顆粒%酒石痠託特囉定片%膀胱過度活動癥%尿急
령작조인과립%주석산탁특라정편%방광과도활동증%뇨급
Lingshao-Zaoren particle%Tolterodine tartrate tablet%Overactive bladder syndrome%Urgent urination
目的:评价苓芍枣仁颗粒联合酒石酸托特罗定片治疗女性膀胱过度活动症(overactive bladder,OAB)的有效性。方法收集2012年12月至2013年7月中国中医科学院西苑医院泌尿外科女性膀胱过度活动症门诊患者50例,按随机数字表法将患者分为两组各25例。对照组采用酒石酸托特罗定片治疗,治疗组在对照组治疗基础上配合苓芍枣仁颗粒治疗,两组均治疗4周后,通过膀胱过度活动症状量表(OBASS)和尿急量表的评分比较,评价两组患者的临床疗效。结果同组治疗前后OBASS评分[治疗组分别为(12.16±1.39)分、(3.24±0.61)分,对照组分别为(13.12±1.45)分、(8.81±1.55)分]比较,差异有统计学意义(P<0.01);尿急量表评分[治疗组分别为(3.99±0.78)分、(1.04±0.72)分,对照组分别为(4.01±0.71)分、(2.61±0.88)分]比较,差异有统计学意义(P<0.01)。两组治疗后 OABSS 评分、尿急评分比较,差异均有统计学意义(P 均<0.01)。结论苓芍枣仁颗粒联合酒石酸托特罗定片治疗膀胱过度活动症的效果优于单用酒石酸托特罗定片。
目的:評價苓芍棘仁顆粒聯閤酒石痠託特囉定片治療女性膀胱過度活動癥(overactive bladder,OAB)的有效性。方法收集2012年12月至2013年7月中國中醫科學院西苑醫院泌尿外科女性膀胱過度活動癥門診患者50例,按隨機數字錶法將患者分為兩組各25例。對照組採用酒石痠託特囉定片治療,治療組在對照組治療基礎上配閤苓芍棘仁顆粒治療,兩組均治療4週後,通過膀胱過度活動癥狀量錶(OBASS)和尿急量錶的評分比較,評價兩組患者的臨床療效。結果同組治療前後OBASS評分[治療組分彆為(12.16±1.39)分、(3.24±0.61)分,對照組分彆為(13.12±1.45)分、(8.81±1.55)分]比較,差異有統計學意義(P<0.01);尿急量錶評分[治療組分彆為(3.99±0.78)分、(1.04±0.72)分,對照組分彆為(4.01±0.71)分、(2.61±0.88)分]比較,差異有統計學意義(P<0.01)。兩組治療後 OABSS 評分、尿急評分比較,差異均有統計學意義(P 均<0.01)。結論苓芍棘仁顆粒聯閤酒石痠託特囉定片治療膀胱過度活動癥的效果優于單用酒石痠託特囉定片。
목적:평개령작조인과립연합주석산탁특라정편치료녀성방광과도활동증(overactive bladder,OAB)적유효성。방법수집2012년12월지2013년7월중국중의과학원서원의원비뇨외과녀성방광과도활동증문진환자50례,안수궤수자표법장환자분위량조각25례。대조조채용주석산탁특라정편치료,치료조재대조조치료기출상배합령작조인과립치료,량조균치료4주후,통과방광과도활동증상량표(OBASS)화뇨급량표적평분비교,평개량조환자적림상료효。결과동조치료전후OBASS평분[치료조분별위(12.16±1.39)분、(3.24±0.61)분,대조조분별위(13.12±1.45)분、(8.81±1.55)분]비교,차이유통계학의의(P<0.01);뇨급량표평분[치료조분별위(3.99±0.78)분、(1.04±0.72)분,대조조분별위(4.01±0.71)분、(2.61±0.88)분]비교,차이유통계학의의(P<0.01)。량조치료후 OABSS 평분、뇨급평분비교,차이균유통계학의의(P 균<0.01)。결론령작조인과립연합주석산탁특라정편치료방광과도활동증적효과우우단용주석산탁특라정편。
Objective To evaluate the efficacy ofLingshao-Zaoren particle combined with Tolterodine Tartrate tablet in the treatment of overactive bladder in women.Methods A total of fifty female patients diagnosed with overactive bladder were randomized to receivingLingshao-Zaoren particle combined with Tolterodine Tartrate tablet group(treatment group,n=25) or only Tolterodine Tartrate tablet group(control group, n=25). Both groups were treated for 4 weeks. Changes of scores from the Overactive Bladder Symptom Scale (OBASS) and the Urgent Urination Scale were assessed.Results The scores from the OBASS improved significantly after treatment than those before treatment in both groups(in the treatment group: 3.24±0.61vs.12.16± 1.39,P<0.01; in the control group: 8.81±1.55vs.13.12±1.45,P<0.01) and so did the Urgent Urination Scale (in the treatment group: 1.04±0.72vs. 3.99±0.78,P<0.01; in the control group: 2.61±0.88vs.4.01±0.71,P<0.01) . There were significantly greater improvements in the scores from the OBASS and the Urgent Urination Scale in the treatment group than those in the control group(allP<0.01).ConclusionLingshao-Zaoren particle combined with Tolterodine Tartrate tablet was superior to only Tolterodine Tartrate tablet for the treatment of overactive bladder in women.